| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |